Search Results - "Aytug, Serhat"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Assessment of the utility of the high-dose dexamethasone suppression test in confirming the diagnosis of Cushing disease by Aytug, Serhat, Laws, Jr, Edward R, Vance, Mary Lee

    Published in Endocrine practice (01-03-2012)
    “…To determine the utility of high-dose dexamethasone suppression (HDDS) tests to confirm the diagnosis of Cushing disease (CD). In this retrospective study, we…”
    Get more information
    Journal Article
  2. 2

    Impaired IRS‐1/PI3‐kinase signaling in patients with HCV: A mechanism for increased prevalence of type 2 diabetes by Aytug, Serhat, Reich, David, Sapiro, Lawrence E., Bernstein, David, Begum, Najma

    Published in Hepatology (Baltimore, Md.) (01-12-2003)
    “…Patients with hepatitis C virus (HCV) infection have a greater risk of developing type 2 diabetes mellitus. However, the mechanism of this association is…”
    Get full text
    Journal Article
  3. 3

    Long-term kidney transplant outcome in obese patients in a predominantly African American population by Karabicak, Ilhan, Aytug, Serhat, Lewis, Shari, Shah, Syed, Sumrani, Nabil, Hayat, Amir, Distant, Dale A., Salifu, Moro O.

    Published in Clinical transplantation (01-05-2011)
    “…Karabicak I, Aytug S, Lewis S, Shah S, Sumrani N, Hayat A, Distant DA, Salifu MO. Long‐term kidney transplant outcome in obese patients in a predominantly…”
    Get full text
    Journal Article
  4. 4

    New-onset diabetes after hemodialysis initiation: impact on survival by Salifu, Moro O, Abbott, Kevin C, Aytug, Serhat, Hayat, Amir, Haria, Dhiren M, Shah, Syed, Friedman, Eli A, Delano, Barbara G, McFarlane, Samy I, Hurst, Frank P, Flom, Peter L, Jindal, Rahul M

    Published in American journal of nephrology (01-01-2010)
    “…The incidence of new-onset diabetes after initiation of hemodialysis (NODAD) and its impact on survival is not known. We used data from the United States Renal…”
    Get more information
    Journal Article
  5. 5

    Posttransplant diabetes and hypertension: Pathophysiologic insights and therapeutic rationale by Salifu, Moro O., Tedla, Fasika, Aytug, Serhat, Hayat, Amir, McFarlane, Samy I.

    Published in Current diabetes reports (01-06-2008)
    “…New-onset diabetes after transplantation and hypertension are very common after renal transplantation and are associated with adverse graft and cardiovascular…”
    Get full text
    Journal Article
  6. 6

    Impaired IRS-1/PI3-kinase signaling in patients with HCV: A mechanism for increased prevalence of type 2 diabetes by Aytug, Serhat, Reich, David, Sapiro, Lawrence E., Bernstein, David, Begum, Najma

    Published in Hepatology (Baltimore, Md.) (01-12-2003)
    “…Patients with hepatitis C virus (HCV) infection have a greater risk of developing type 2 diabetes mellitus. However, the mechanism of this association is…”
    Get full text
    Journal Article
  7. 7

    Challenges in the diagnosis and management of new-onset diabetes after transplantation by Salifu, Moro O, Tedla, Fasika, Murty, Preethi V, Aytug, Serhat, McFarlane, Samy I

    Published in Current diabetes reports (01-06-2005)
    “…With the availability of newer and more potent immunosuppressive agents, post-transplant survival has markedly improved. However, these agents, together with…”
    Get full text
    Journal Article
  8. 8

    Challenges in the diagnosis and management of renal artery stenosis by Salifu, Moro O, Haria, Dhiren M, Badero, Olurotimi, Aytug, Serhat, McFarlane, Samy I

    Published in Current hypertension reports (01-06-2005)
    “…Renal artery stenosis (RAS) is a common cause of secondary hypertension, with the activation of the renin-angiotensin-aldosterone system being the…”
    Get full text
    Journal Article